Sleep Disturbances among Older Adults in the United States, 2002–2012: Nationwide Inpatient Rates, Predictors, and Outcomes
Alyssa A. Gamaldo1,2,3† 
May A. Beydoun2*† Hind A. Beydoun4 Hailun Liang5 Rachel E. Salas6 Alan B. Zonderman2 Charlene E. Gamaldo6‡ Shaker M. Eid4‡- 1School of Aging Studies, University of South Florida, Tampa, FL, USA
- 2Behavioral Epidemiology Section, Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, Baltimore, MD, USA
- 3Human Development and Family Studies, Penn State University, State College, PA, USA
- 4Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 5Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
- 6Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Objective/Background: We examined the rates, predictors, and outcomes [mortality risk (MR), length of stay (LOS), and total charges (TC)] of sleep disturbances in older hospitalized patients.
Patients/Methods: Using the U.S. Nationwide Inpatient Sample database (2002–2012), older patients (≥60 years) were selected and rates of insomnia, obstructive sleep apnea (OSA) and other sleep disturbances (OSD) were estimated using ICD-9CM. TC, adjusted for inflation, was of primary interest, while MR and LOS were secondary outcomes. Multivariable regression analyses were conducted.
Results: Of 35,258,031 older adults, 263,865 (0.75%) had insomnia, 750,851 (2.13%) OSA and 21,814 (0.06%) OSD. Insomnia rates increased significantly (0.27% in 2002 to 1.29 in 2012, P-trend < 0.001), with a similar trend observed for OSA (1.47 in 2006 to 5.01 in 2012, P-trend < 0.001). TC (2012 $) for insomnia-related hospital admission increased over time from $22,250 in 2002 to $31,527 in 2012, and increased similarly for OSA and OSD; while LOS and MR both decreased. Women with any sleep disturbance had lower MR and TC than men, while Whites had consistently higher odds of insomnia, OSA, and OSD than older Blacks and Hispanics. Co-morbidities such as depression, cardiovascular risk factors, and neurological disorders steadily increased over time in patients with sleep disturbances.
Conclusion: TC increased over time in patients with sleep disturbances while LOS and MR decreased. Further, research should focus on identifying the mechanisms that explain the association between increasing sleep disturbance rates and expenditures within hospital settings and the potential hospital expenditures of unrecognized sleep disturbances in the elderly.
Introduction
Around half of community-dwelling older adults report sleep concerns (Neikrug and Ancoli-Israel, 2010), with overt sleep disorders frequently observed in this population (Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010; Roepke and Ancoli-Israel, 2010). Specifically, insomnia and obstructive sleep apnea (OSA) are two common disorders affecting Americans 60 years and older (Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010). The hospital, an under-studied setting, is pertinent since undetected or poorly treated sleep disturbances may account for poor prognosis and long-term utilization of hospital services, thereby increasing healthcare expenditures. As such, this study assesses trends of diagnosed sleep disturbances among older adults within the hospital setting and tests test whether these diagnoses rates are associated with hospitalization metrics (e.g., length of stay, mortality risk, and expenditures).
Sleep disturbances are typically comorbid with medical conditions (Gamaldo et al., 2012b), with the latter presenting obvious and unmanageable symptoms driving older adults to seek treatment in these settings. Those co-morbidities include heart disease (Budhiraja et al., 2011), hypertension (Budhiraja et al., 2011), diabetes (Gottlieb et al., 2005), stroke (Olafiranye et al., 2013), immune system dysfunction (Gamaldo et al., 2012b), stomach ulcers (Budhiraja et al., 2011), arthritis (Budhiraja et al., 2011), migraine (Budhiraja et al., 2011), asthma (Budhiraja et al., 2011), chronic obstructive pulmonary disease(COPD; Budhiraja et al., 2011), neurological complaints(Wolkove et al., 2007; Budhiraja et al., 2011), endocrine dysfunction (Budhiraja et al., 2011), depression and anxiety (Benca, 2014; Jaramillo et al., 2015). Severe levels of co-morbidity both threaten optimal patient care and constitute a public health and safety concern. Chronic untreated sleep disturbances are also linked to impaired cognitive functioning (Gamaldo et al., 2010, 2012a; Zimmerman and Aloia, 2012; Ford et al., 2015), increased traffic accidents (Terán-Santos et al., 1999; Budhiraja et al., 2011), worse quality of life (Daley et al., 2009; Ford et al., 2015), increased risk for disability (Daley et al., 2009; Ford et al., 2015), worse workplace productivity (Leger et al., 2012; Ford et al., 2015), and increased mortality (Hublin et al., 2011; Ford et al., 2015), exerting significant economic strain on the healthcare system (Peppard et al., 2013; Shear et al., 2014; Ford et al., 2015).
With population aging, healthcare service consumption will continuously increase amongst this demographic group at risk for developing and/or exacerbating ailments (Kaufmann et al., 2013). Evaluated as common in samples of community-dwelling older adults (Foley et al., 1995), sleep disturbances' rates remain largely unknown among older adult hospital inpatients. Exploring the hospital setting may support the need for healthcare providers to effectively recognize and treat sleep disturbances among older adults, especially if estimated sleep disturbance rates are lower than previously reported, suggesting under-reporting. Despite prior focus on the impact of sleep disturbances on older adults' physical and/or mental health (Wolkove et al., 2007; Gamaldo et al., 2010; Neikrug and Ancoli-Israel, 2010; Roepke and Ancoli-Israel, 2010), fewer studies examined the ramifications of older adults' sleep disturbances on their interface with the healthcare system particularly as it pertains to inpatient hospital stays. Limited research is available to understand sleep disturbance rates among older adults, examine trends over time, and assess whether co-morbidities and other individual-level and hospital-level characteristics are related to a sleep disturbance diagnosis (i.e., insomnia, OSA, or other sleep disturbance) and hospitalization outcomes.
The current study investigated five key objectives: (A) To assess over time trends in the rates of insomnia, OSA, and other sleep disturbances (OSD) among hospitalized older adults; (B) To compare patients with and without each of the three classes of sleep disturbance, in terms of co-morbidities, patient-level, and hospital-level characteristics in a recent period of time; (C) To compare hospitalization outcomes in patients with and without each of the three classes of sleep disturbance, mortality risk (MR), length of stay (LOS), and total charges (TC) in a recent period of time; (D) To examine trends in co-morbidity rates and outcomes of hospitalization among patients with each of the three classes of sleep disturbance; (E) To assess the predictive value of patient-level and hospital-level characteristics on outcomes of hospitalization among recently admitted patients with any of the three classes of sleep disturbance.
Materials and Methods
Database and Study Participants
The Nationwide Inpatient Sample (NIS) is one of several databases and software tools implemented by the Healthcare Cost and Utilization Project (HCUP)1, a federal-state-industry partnership sponsored by the Agency for Healthcare Research and Quality (AHRQ). To date, the NIS is the largest all-payer hospital inpatient care database in the United States. Each year, NIS collects data on nearly 7–8 million hospital stays, reflecting discharges from ~1000 hospitals, a probability sample from HCUP State Inpatient Databases (SID). The sampling probability is ~20% and the design is stratified covering U.S. non-rehabilitation, community hospitals, with all acute care hospital discharges in the United States as the target universe. The NIS was developed to provide information on hospital utilization, charges, and quality of care in the United States
NIS defined its sampling strata using five hospital characteristics contained in the AHA hospital files: (1) Geographic Region—Northeast, Midwest, West, and South; (2) Control—public, private not-for-profit, and proprietary; (3) Location—urban or rural; (4) Teaching Status—teaching or non-teaching, (5) Bed Size—small, medium, and large.
The NIS includes clinical and resource-use information contained within a typical discharge abstract, protecting privacy of patients, physicians, and hospitals. Although NIS data are available since 1988, severity and comorbidity measures contained in the severity file became available from 2002 onwards. In addition, NIS did not add new states to its 35-state geographical coverage since 2002 providing more homogeneity in data acquisition over time. Therefore, we used NIS data from 2002 to 2012. Despite the redesign made in 2012, examining trends in means and proportions over the years is possible by inclusion of trend weights, allowing for comparable estimates for all years. (See Appendix I for more details).
Diagnostic Criteria
Each year, the core file of NIS provided the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for diagnosis and procedure, from discharge abstract, with information recoded retrospectively. The latest changes to ICD-9-CM codes are provided for 2011: http://www.cdc.gov/nchs/data/icd/ICD-9-CM%20TABULARADDENDAfy12.pdf. The number of diagnoses provided per patient varied by State. However, the number was truncated at 15 for both diagnoses and procedures because few cases had more than 15 diagnoses or procedures between 2002 and 2008. Nevertheless, two variables were provided indicating the total number of diagnoses and procedures. Between 2009 and 2012, up to 25 diagnoses were provided. However, for equal opportunity for a specific diagnosis, only the first 15 were considered for any year.
Among the possible 15 diagnoses, the first ranked diagnosis is termed “principal diagnosis.” In our main analysis, trends, characteristics, and outcomes of sleep disturbance as “any diagnosis” of 15 was of primary interest. ICD-9-CM codes used for each class of sleep disturbance as determined by clinical sleep specialist are outline in Appendix II.
Co-morbidity Measure
The AHRQ comorbidity measures identify coexisting medical conditions not directly related to principal diagnosis or main reason for admission, and are likely to have originated before hospital stay. The AHRQ comorbidity measures were developed as one of the HCUP tools. Complete documentation on the comorbidity measures is available on the HCUP User Support Website under Tools & Software. (http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp). In the present study, all 29 co-morbidities (http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/Table2-FY12-V3_7.pdf) were included in our analyses. In particular, we examined the likelihood of specific co-morbid conditions among patients with conditions of “insomnia,” “OSA,” and “OSD” and how this likelihood changed over the years.
Outcome Measures
Three outcome measures of hospitalization were considered, MR upon discharge (0, discharged alive; 1, discharged dead), LOS (days) and TC ($). In particular, we were interested in comparing outcomes in patients with and without a particular “sleep disturbance” in 2012 and examining changes over time among patients with a sleep disturbance between the years of 2002 and 2012. For TC trends, values were inflated to 2012 dollars using the consumer price index.
Covariates
Patient-Level Characteristics
Among patient-level characteristics, we included age (continuous and categorized as 60–64, 65–69, 70–74, 75–79, 80–84, and 85+), sex, race (White, Black, Hispanic, Asian/Pacific Islander, Native American, and Other), median household income for zip code of patient (expressed as quartiles), insurance status (Medicare, Medicaid, Private insurance, self-pay, no charge and other) and admission day (weekday vs. weekend).
Hospital-Level Characteristics
We examined hospital-level characteristics in relation to “sleep disturbance” status and outcomes of healthcare utilization, which included bed size (Small, Medium, Large), ownership of hospital (Government/nonfederal, private non-profit, private investor-owned), location/teaching status of the hospital (rural, urban, non-teaching, urban teaching) and region of the hospital (Northeast, Midwest, South and West).
Statistical Analysis
We used Stata 13.0 (StataCorp, College Station, TX), (STATA, 2013) to analyze data while accounting for survey design complexity based on guidelines outlined by HCUP NIS through incorporation of sampling weights, primary sampling units and strata. Population estimates of proportions, means, and regression coefficients were made (svy commands; Stata, 2013). Standard errors were estimated using Taylor series linearization, taking into account sampling weights, strata (combination of five hospital characteristics) and primary sampling units (hospital ID). Multiple regression modeling was also conducted, mainly using linear and logistic regression models, while accounting for sampling design complexity. When waves were combined to examine trends of sleep disturbance rates and outcomes of hospitalization, trend weights were used to ensure redesigned 2012 NIS could be incorporated into the analysis of trends. In order to facilitate analysis of trends using multiple years of NIS data, AHRQ developed new discharge trend weights for the 1993–2011 NIS. These weights were calculated in the same way as the weights for the redesigned 2012 NIS, and were designed for use instead of the original NIS discharge weights for trends analysis. Given that our present trend analysis spans through 2012, starting from 2002, trend weights were used before 2012 data to make estimates comparable to the new 2012 NIS design.
Following our key objectives: (A) We first explored proportions of adults 60 years or older who were diagnosed with “insomnia,” “OSA,” or “OSD” as any of 15 possible recorded diagnoses upon discharge. This analysis was conducted from 2002 to 2012, stratifying by sex and age groups. Overall, within each sex and sex-age groups, we assessed trends by conducting logistic regression analyses with year as the only covariate and “sleep disturbance status” status the binary outcome. (B) Sleep disturbance status (yes vs. no) among patients for the year 2012—the most recent available year in NIS—were compared by logistic regression with various predictors of sleep disturbance, including patient-level and hospital-level characteristics as well as patient co-morbidities; (C) Using 2012 wave of data among older adults aged 60 years or older, we also compared outcomes of hospitalizations for sleep disturbance and non-sleep disturbance patients by logistic and linear regression models with insomnia, OSA, and OSD status as the main predictor of those outcomes, controlling for patient-level, and hospital-level characteristics, and co-morbidities; (D) Using data from 2002 through 2012, we conducted a trends analysis of co-morbidities among patients with each of the three classes of sleep disturbance, by estimating proportions with their SE and conducting a logistic regression model for each comorbidity with year being the only predictor. Similarly, we examined trends in MR, LOS, and TC using the same methods (i.e., proportion estimation and multiple regression models with year as the only covariates) among patients with each class of sleep disturbance. Another linear model was also conducted to examine the net trend in those three parameters after adjustment for age, sex, and total number of co-morbidity; (E) Finally, and using analyses similar to (C) but restricting the sample to patients with any sleep disturbance, we ran several regression models testing predictors of hospitalization outcomes in 2012 among older adults, while including insomnia, OSA and OSD status as additional covariates in the model. The secondary analysis of NIS was approved by the institutional review boards of the NIH and Johns Hopkins School of Medicine.
Results
Of 87,039,711 patients sampled from 2002 to 2012, NIS (weighted mean age ± SE: 47.9 ± 0.2, and weighted proportion female ± SE: 58.5% ± 0.1, weighted number of discharges: 411,487,801), 35,258,031 were aged 60 years or older (weighted mean age ± SE: 75.37 ± 0.03, and weighted proportion female ± SE: 56.0% ± 0.1). The total weighted number of hospital discharges of older adults aged 60 years or older between 2002 and 2012 was estimated at 166,871,086 nationwide. In 2012, the unweighted number of discharges over 60 years of age was 2,825,130; the weighted number was 14,126,650.
Of the 35,258,031 older adults in the unweighted sample (2002–2012), 263,865 had insomnia as “any diagnosis” (weighted percent of discharges ± SE: 0.75 ± 0.01); 750,851 had an OSA diagnosis (weighted percent of discharges ± SE: 2.14 ± 0.04), 21,814 had a diagnosis of OSD (weighted percent of discharges ± SE: 0.06 ± 0.00).
Table S1 and Figure 1 shows the trends in weighted proportions of all three classes of sleep disturbance as any diagnosis, stratifying by sex (Objective A). Overall and among men and women, there was an increasing trend in the share of hospitalizations of older adults who were diagnosed with insomnia, OSA, and OSD. A linear trend was particularly observed for insomnia diagnosis, with an estimated rate of 0.27% overall in 2002 rising linearly up to 1.29% in 2012. In contrast, OSA was not diagnosed until 2005 in this inpatient sample (estimated rate of 0.21%) and its rate rose sharply thereafter to reach a level of 5% out of all hospitalizations in 2012. Men tended to have higher rates of OSA compared to women in all years, while the reverse gender difference was true for insomnia (Table S1). Stratifying by both sex and age group, Table S2 and Figures 2A–F shows that in later years (particularly beyond 2009), the young-old (60–64 years) tended to have higher rates of insomnia and OSA compared to older groups and specifically the oldest-old (85+).
Figure 1. Sex-specific and overall time trends in insomnia, obstructive sleep apnea. (OSA) and other sleep disturbances (OSD) (as any diagnosis) rates in the inpatient older adult population (60+y); NIS, 2002–2012.
Figure 2. (A–F) Sex- and age-specific time trends in insomnia, obstructive sleep apnea. (OSA) and other sleep disturbances (OSD) (as any diagnosis) rates in the inpatient older adult population (60+y); NIS, 2002–2012.
Table 1 shows the association of patient and hospital-level characteristics with all three classes of sleep disturbance status among hospitalized older adults (Objective B). In general, insomnia status was positively associated with being female, belonging to a younger age group, a White ethnicity, higher income, having Medicare as the primary expected insurance, admission on a weekday, admission to a small bed size (vs. large bed size) or private, investor-owned hospital as opposed to government, and with rural hospitalizations. Geographically speaking, the Northeast had the lowest likelihood of insomnia diagnosis whereas the West had the highest rates. Several co-morbidities were more prevalent in non-insomnia cases compared to insomnia, while others showed no difference. The few exceptions whereby having a co-morbidity was independently linked to higher odds of insomnia included alcohol abuse (OR = 1.17, 95% CI:1.10–1.25, p < 0.001), anemia (OR = 1.07, 95% CI:1.04–1.11, p < 0.001), depression (OR = 2.73, 95%CI: 2.66–2.81, p < 0.001), drug abuse (OR = 1.56, 95%CI:1.44–1.70, p < 0.001), hypertension (OR = 1.09, 95%CI:1.06–1.12), hypothyroidism (OR = 1.08, 95%CI: 1.05–1.11, p < 0.001), neurological disorders (OR = 1.17, 95%CI:1.13–1.21) and psychoses (OR = 1.98, 95%CI:1.89–2.08, p < 0.001).
Table 1. Associations of patient and hospital characteristics with insomnia, OSA, and OSD (1, Yes; 0, No) among the US inpatient older adult population: multiple logistic regression models (Unweighted N = 2,825,283; Weighted N = 14,126,415)*, NIS 2012.
In contrast, the odds of an OSA diagnoses was greater among men, but lower with age, significantly higher among Whites and patients with higher income, and generally higher among Medicare beneficiaries. The odds for diagnosis with OSA was lower in weekend admissions as was insomnia, but the odds was higher with bed size, highest in private non-profit and urban hospitals, while remaining lowest in the Northeast. Several co-morbidities had independent positive associations with OSA and many of those intersected with those observed with insomnia. These included rheumatoid arthritis, congestive heart failure, depression, diabetes (both uncomplicated and complicated), hypertension, hypothyroidism, neurological disorders, pulmonary circulation disorders, renal failure, and most importantly obesity (OR = 5.15, 95%CI: 5.05–5.25, p < 0.001).
The likelihood of OSD diagnoses was not modified by gender or income though was still lowest among the oldest-old, and highest among Whites. Hospital-level characteristics were associated with OSD in a way similar to that of OSA, with the odds doubled in the Midwest compared to the Northeast. Most notably, while alcohol abuse was inversely related to OSD, drug abuse was among the strongest predictors of OSD (OR = 8.52, 95%CI:7.02–10.34, p < 0.001) followed by peptic ulcer (OR = 4.58, 95%CI:1.72–12.20, p = 0.002). Other co-morbidities that were positively linked to OSD included depression, hypertension, neurological disorders, obesity, and psychoses.
Table 2 displays findings from multiple regression models testing associations between the three classes of sleep disturbance as predictors of MR, LOS, and TC, while adjusting for individual-level and hospital-level characteristics (Objective C). Generally, diagnosis with any of the three sleep disturbances was associated with lower MR and lower TC compared to non-diagnosis. LOS was higher for insomnia vs. non-insomnia and for OSD vs. non-OSD, though the reverse pattern was observed for OSA status.
Table 2. Outcomes of healthcare utilization (MR, LOS, and TC) among older adults by sleep disturbance status, patient-level, and hospital-level characteristics: multiple logistic and OLS regression models, NIS 2012.
Among hospitalized older adults who were diagnosed with each of the three classes of sleep disturbances, trends in co-morbidities from 2002 to 2012 are presented in Table S3 (Objective D). Overall, the average number of co-morbidities increased steadily from 2.28 in 2002 to 3.10 in 2012 for insomnia, from 3.11(2005) to 3.87(2012) for OSA and 1.92(2002) to 3.19(2012) for OSD. Some of the most prevalent co-morbidities (>10% in 2012) in insomnia patients included deficiency anemia (~14% in 2002 → 21% in 2012), chronic pulmonary disorder (22% in 2002 → 24% in 2012), depression (20% in 2002 → 27% in 2012), uncomplicated diabetes (~15% in 2002 → 21% in 2012), hypertension (52% in 2002 → 70% in 2012), hypothyroidism (14% in 2002 → 20% in 2012), fluid/electrolyte disorder (18% in 2002 → 27% in 2012), neurological disorders (6.3% in 2002 → 12.5% in 2012), and renal failure (3% in 2002 → 12% in 2012). Except for congestive heart failure, the rates among insomnia patients rose over time for most co-morbidities. Among OSA patients, the most prevalent co-morbidities included those observed among insomnia patients in addition to obesity (42% in 2012) and congestive heart failure (19% in 2012). Despite similar comorbidity patterns between the three classes of sleep disturbance, OSD had the highest co-morbidity with drug abuse compared to insomnia and OSA (7.5% in 2012 vs. 1.8 for insomnia and 0.9% in OSA).
In parallel with the rise in co-morbidities among older adult patients with sleep disturbance, TC rose steadily from an average of $22,250/admission in 2002 to $38,177/admission in 2012 for insomnia with similar mean annual changes observed for OSA and OSD ($1414/year for OSA, $1635/year for OSD and $1722/year for insomnia). The rate of increase in cost was slightly attenuated but remained significant after adjustment for age, sex, and total number of co-morbidities. However, both MR and LOS have been markedly reduced over-time, with the exception of MR for OSD (p > 0.05). In particular, MR dropped steadily from 1.5% in 2002 to 1.0% in 2012 among insomnia patients while mean LOS was reduced from 6.1 days in 2002 to 5.4 days in 2012. Those rates of decrease over time were even more marked after control was made on age, sex, and total number of co-morbidities (Table S4, Objective D).
Using data from 2012 on inpatient older adults with “any sleep disturbance,” we tested predictors of outcomes of hospitalization (Table 3, Objective E). MR was lower among women who also had a significantly lower TC. MR increased linearly with age, with longer LOS but lower TC observed in the older groups. TC was also higher among Hispanics and other ethnic groups compared to Whites, with Blacks having significantly lower MR and higher LOS compared to Whites. The 4th quartile of income was significantly more expensive in terms of TC compared to the 1st quartile, though LOS was shorter and MR lower.
Table 3. Outcomes of healthcare utilization (MR, LOS, and TC) among older adults with “any sleep disturbance,” patient-level and hospital-level characteristics: multiple logistic and OLS regression models, NIS 2012.
Discussion
This study is the first to utilize a large national healthcare database to comprehensively examine trends in sleep disturbance diagnoses of insomnia, OSA, and OSD among hospitalized older adults in the United States and whether co-morbidities and outcomes are related to disturbance status. Moreover, this study tested both patient-level and hospital-level predictors of sleep disturbance status and outcomes of hospitalization.
Our study observed that the proportion of older adults with a sleep diagnosis has increased significantly over the last decade. Insomnia and OSA diagnoses in older adults have more than tripled from 2002 to 2012, while diagnoses for OSD have almost doubled over this period. A study using the National Health Interview Survey (Ford et al., 2015) observed similar increasing rate trends specifically for insomnia from 2002 (17.5%) and 2012 (19.2%) with adults 18 years and older. The study also observed greater rate changes over time for the youngest-old (55–64 years: 22.1–24.2%) and middle-old (65–74 years: 18.6–21.3%) than the oldest-old (75 years and older: 20.5–20.7%) age groups. The current study expands upon these findings, in that we observed that the youngest-old (60–64 years) tended to have greater rates of change for both insomnia and OSA than the older age groups (65 years and older). A possible explanation for this finding is that a percentage of the oldest-old with sleep disturbances and comorbid health conditions may have died at earlier ages. Thus, a survivor effect may be occurring where the oldest-old adults with sleep disturbances are a selected group of individuals with less severe sleep disturbances and/or comorbid medical conditions. Nevertheless, a growing body of evidence has shown that (short or long) sleep duration (Cohen-Mansfield and Perach, 2012; Ensrud et al., 2012; Garde et al., 2013; Jung et al., 2013; Kakizaki et al., 2013; Kurina et al., 2013; Yeo et al., 2013; Azevedo Da Silva et al., 2014; Benito-León et al., 2014; Duggan et al., 2014; Pan et al., 2014; Rod et al., 2014; Xiao et al., 2014; Cai et al., 2015; Hall et al., 2015), sleep disturbances (Ensrud et al., 2012; Omachi et al., 2012; Rod et al., 2014), and obstructive sleep apnea (OSA; Ge et al., 2013; Lee et al., 2013; Lockhart et al., 2013; Muraja-Murro et al., 2013; Stanchina et al., 2013; Kendzerska et al., 2014; Louis et al., 2014; Marshall et al., 2014) may predict all-cause (Seicean et al., 2011; Ensrud et al., 2012; Howrey et al., 2012; Johansson et al., 2012; Nieto et al., 2012; Omachi et al., 2012; Garde et al., 2013; Ge et al., 2013; Jung et al., 2013; Kakizaki et al., 2013; Kurina et al., 2013; Lee et al., 2013; Lockhart et al., 2013; Muraja-Murro et al., 2013; Yeo et al., 2013; Louis et al., 2014; Marshall et al., 2014; Pan et al., 2014; Rod et al., 2014; Xiao et al., 2014; Hall et al., 2015; Rahman and Adjeroh, 2015), cardiovascular- (Nieto et al., 2012; Garde et al., 2013; Ge et al., 2013; Kakizaki et al., 2013; Yeo et al., 2013; Azevedo Da Silva et al., 2014; Marshall et al., 2014; Rod et al., 2014; Xiao et al., 2014), cancer- (Yeo et al., 2013; Marshall et al., 2014; Rod et al., 2014; Xiao et al., 2014; Rahman and Adjeroh, 2015), and dementia-specific (Cai et al., 2015) mortality. Another explanation is the increased number of co-morbidities with age that are deemed more serious to report than sleep disturbances thus those diagnoses are often missed at older ages given that only 15 diagnoses are allowed for this analysis. Generally speaking, several reasons have been proposed for the increasing sleep disturbances rates including, but not limited to, the following: (1) increased number of health conditions; (2) increase in obesity rates; (3) increase in perceived stress; (4) poor sleep habits/hygiene; (5) increase in shift work; (6) increased use of electronic devices, particularly close to bedtime, a behavior that has become salient in the US, though possibly less so among older adults (Pallesen et al., 2014; Ford et al., 2015).
While in-hospital LOS and MR among admissions with sleep disturbances has decreased, TC has increased over time. Specifically, insomnia-related hospital charges have increased from $22,250 to $38,177, OSA-related hospital charges have increased from $37,561 to $46,518, and OSD-related hospital charges have increased from $18,264 to $35,450, with those trends only partly explained by age, sex and total comorbidity distribution changes over the years. In comparison to younger adults, older adults have shown to incur direct (inpatient, outpatient, pharmacy, and emergency room) charges greater than $1253 for untreated sleep disturbances, such as insomnia (Ozminkowski et al., 2007). Particularly in light of recent data suggesting poorer health outcomes and increased rates of readmission in those individuals suffering with untreated sleep disorders, increased efforts aimed at training providers delivering both the acute (inpatient) and primary/preventive health care may assist in reducing hospitalization costs. The reduction in MR and LOS may be explained by the improved in-hospital procedures to stabilize/improve health co-morbidities (e.g., hypertension and diabetes) often associated with sleep disturbances. One study partially supports this explanation, by observing that in-hospital mortality risk appeared to decline significantly in OSA patients after adjusting for health comorbidities and demographic characteristics (Lyons et al., 2015). Consequently, it is possible that increased costs may be a result of implementing a variety of in-hospital procedures for stabilizing/improving older adults' health status, especially if they have complex etiologies, including sleep disturbances and other co-morbidities, that leads to a complex case-mix requiring multifaceted interventions. The increased costs, but reduced MR and LOS, may also reflect enhanced techniques for early disease detection and copious treatment resources.
Our study observed several patient characteristic differences across the three classes of sleep disturbances. Over the last decade men tended to have higher rates for OSA, while women tend to have higher rates for insomnia. These gender differences in OSA and insomnia rates have been supported in previous studies (Ohayon et al., 2004; Wolkove et al., 2007; Salas et al., 2014). In terms of hospitalization outcomes, women with any type of sleep disturbance tended to have lower MR and lower TC than men. It is unclear what physiological, sociological, and/or psychological factors explain the gender differences in OSA, which could assist in developing an approach for improving hospitalization outcomes associated with OSA in men. However, it has been proposed that estrogen deficiency, particularly during the peri-menopausal period, may account for the higher number of women with insomnia (Ohayon et al., 2004; Wolkove et al., 2007).
Interestingly, we observed that older whites had consistently higher rates of insomnia, OSA, and OSD over the last decade than older Blacks and older Hispanics. Furthermore, older Blacks with any type of sleep disturbance appeared to have lower MR, but higher LOS compared to older Whites. Previous literature has observed mixed findings regarding the racial differences in sleep disturbance rates. While some studies have supported our findings that sleep disturbances appear to be higher in older Whites than older Blacks (Redline et al., 1997; Durrence and Lichstein, 2006), other studies have observed that sleep disturbances appear to be higher in older Blacks than older Whites (Foley et al., 1999; Ancoli-Israel et al., 2002). A potential explanation for this inconsistent finding is the different methodological approaches. The current study uses clinical diagnostic codes, such as ICD-9-CM, given by a health provider to estimate sleep disturbance; however, it is unclear what diagnostic tests were given to assess the symptoms/signs common to each sleep disturbance. Many of the previous studies have estimated sleep disturbance, particularly OSA, after participants have completed clinical evaluation, standardized questionnaires, an in-lab overnight sleep study, and/or in-home sleep testing (HST; Salas et al., 2014). Furthermore, many of the previous studies have actively recruited participants within the community, while this study is accounting for individuals in the community that sought medical care. Given Blacks are less likely than Whites to utilize health care services and/or more likely to utilize health care resources with severe symptomology (Weech-Maldonado et al., 2014), our study may be underestimating the rates of sleep disturbances and the MR associated with sleep disturbances within older Blacks. However, our finding may further provides support that sleep disturbances, particularly in Blacks, may be underdiagnosed in the health care setting (Kapur et al., 2002; Benca, 2014; Salas et al., 2014). This is corroborated with findings on income differentials in the rates of sleep disturbance, whereby for both insomnia and OSA, higher income individuals had a higher rate, suggesting higher access to health care, particularly for OSA which requires a sleep study as opposed to insomnia which is only assessed through a clinical diagnosis and patient history.
Primary insurance also appeared to be associated with sleep disturbances. Older adults with Medicare as their primary insurance had higher rates across the classes of sleep disturbances than older adults with a different primary insurance. However, Medicare beneficiaries with any type of sleep disturbance had lower MR, lower LOS, and lower TC in comparison with some of the other primary insurance programs (i.e., Medicaid, private, and self-pay). Since there are several programs available under Medicare (e.g., Medicare Advantage program (Weech-Maldonado et al., 2014), future studies should explore differences in sleep disturbance rates and hospitalization outcomes across the Medicare plans.
Similar to previous literature, the current study found that sleep disturbances are associated with cardiovascular risk factors (e.g., diabetes, hypertension, and obesity; (Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010; Beccuti and Pannain, 2011; Lyons et al., 2015), psychiatric disorders (e.g., depression and psychoses; Wolkove et al., 2007; Kaufmann et al., 2011), neurological diagnoses (e.g., AD, dementia, Parkinson's Disease; Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010), cancer (Neikrug and Ancoli-Israel, 2010), and alcohol consumption (Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010). In addition, our results indicated an increase in the average number of health conditions over the last decade. Furthermore, our results highlighted that many co-morbidities (depression, cardiovascular risk factors, and neurological disorders) steadily increased over time, which supports a coupling linear trend between these medical conditions and sleep disturbances. These findings further support the proposed rationale that the increased number of health conditions and increased rates of particular health conditions (e.g., obesity) in the last decade is associated with the increased rates in sleep disturbances over time (Kronholm et al., 2008; Pallesen et al., 2014; Ford et al., 2015). The coupled increase trend in sleep disturbances and medical conditions may also account for the increasing in-hospital costs.
Hospital characteristics differed across the three classes of sleep disturbance. Rates for insomnia and OSD were higher in investor-owned hospitals, hospitals located in rural areas, and hospitals with smaller bed sizes. In contrast, rates for OSA were higher in non-profit hospitals, hospitals located in urban areas, and hospitals with larger bed sizes. There is only limited research on these differences in hospital characteristics as it relates to various types of sleep disturbances. It is possible that neighborhood characteristics (e.g., noise pollution, lighting, and air quality in neighborhoods near hospital) and individual characteristics (e.g., proportion of individuals below the poverty level residing near hospital) may explain these differences. Further research is warranted to understand how some of these modifiable factors may reduce the number of individuals with sleep disturbances, and the subsequent hospital costs associated with sleep disturbances.
Despite many of study strengths including national representativeness, large sample size, and availability of extensive healthcare data that allow for trends analyses, the current study is not without limitations. First, it relied on administrative database using ICD-9-CM codes. These codes may not be categorized based upon the standard diagnosis criteria for sleep disorders, which may lead to diagnosis misclassification. However, the AHRQ periodically ensures quality checks with internal and external validation. Second, discharge abstracts are de-identified, thus precluding longitudinal analyses. Third, the structure of NIS limits our ability to detect multiple admissions and/or discharges from the same condition per patient, including those with insomnia. In addition, detailed patient data are lacking such that individual medication regimens and laboratory results are missing. This precludes examining important covariates we would otherwise have included. Older adults are likely taking a number of medications. Previous research has suggested that this polypharmacy patient profile is even more prominent amongst older individuals suffering from sleep (Neikrug and Ancoli-Israel, 2010). Future research is needed to explore how the relationship between sleep disturbances and hospitalization characteristics/outcomes is explained by the number and extent of an individual's medication regimen. Fourth, NIS is limited to hospitalized patients with sleep disturbance and thus trend results may not be similar in the community. Nonetheless, sleep disturbances are often underdiagnosed and untreated, particularly within the older adult population (Groth, 2005; Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010) and thus our study's estimated rates are likely conservative. As with any retrospective administrative data analysis, there is potential for bias from missing data; however, it is unlikely that missing data will have a large effect on the results because of the large sample size of the current study. Furthermore, we were unable to compare frequencies of hospitalization between patients with and without sleep disturbance over pre-set periods of time (e.g., a month or a year).
This study observed that while rates of sleep disturbances are increasing within hospital settings, the relatively low rates may reflect that many older adults' sleep disorders remain underdiagnosed. Since older adults' sleep disturbances are associated with an increase in healthcare costs, educational interventions designed to train healthcare professionals in recognizing and effectively treating sleep disturbances may assist in reducing these healthcare expenditures.
Author Contributions
AG: Study conception, literature search and review, plan of analysis, interpretation of findings, write-up of parts of the manuscript, revision of the manuscript. MB: Study conception, plan of analysis, data management, statistical analysis, interpretation of findings, write-up of parts of the manuscript, revision of the manuscript. HB: Plan of analysis, literature search, write-up of parts of the manuscript, revision of the manuscript. HL: Literature search and review, data management, revision of the manuscript. RS: Interpretation of findings, write-up of parts of the manuscript, revision of the manuscript. AZ: Plan of analysis, interpretation of findings, revision of the manuscript. CG: Literature search and review, interpretation of findings, write-up of parts of the manuscript, revision of the manuscript. SE: Plan of analysis, data management, data acquisition, interpretation of findings, revision of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
This study was supported in part by the NIA/NIH/IRP in collaboration with Johns Hopkins University School of Medicine. We would like to thank Ms. Danielle Shaked and Dr. Greg Dore for their internal review of the manuscript.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/article/10.3389/fnagi.2016.00266/full#supplementary-material
Abbreviations
AHRQ, Agency for Healthcare Research and Quality; AIDS, Acquired Immune Deficiency Syndrome; CHF, Congestive Heart Failure; CI, Confidence Interval; HCUP, Healthcare Cost and Utilization Project; ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; LOS, length of stay; MR, Mortality risk; NIS, Nationwide Inpatient Sample; OR, Odds Ratio; OSA, Obstructive Sleep Apnea; OSD, Other sleep disturbances; SE, Standard Error; SID, State Inpatient Databases; TC, total charges.
Footnotes
1. ^Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample (NIS) Documentation. Available online at: http://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp (Accessed February 5, 2015).
References
Ancoli-Israel, S., Stepnowsky, C., Dimsdale, J., Marler, M., Cohen-Zion, M., and Johnson, S. (2002). The effect of race and sleep-disordered breathing on nocturnal BP “dipping”: analysis in an older population. Chest 122, 1148–1155. doi: 10.1378/chest.122.4.1148
Azevedo Da Silva, M., Singh-Manoux, A., Shipley, M. J., Vahtera, J., Brunner, E. J., Ferrie, J. E., et al. (2014). Sleep duration and sleep disturbances partly explain the association between depressive symptoms and cardiovascular mortality: the Whitehall II cohort study. J. Sleep Res. 23, 94–97. doi: 10.1111/jsr.12077
Beccuti, G., and Pannain, S. (2011). Sleep and obesity. Curr. Opin. Clin. Nutr. Metab. Care 14, 402–412. doi: 10.1097/MCO.0b013e3283479109
Benca, R. M. (2014). Diagnosis and treatment of chronic insomnia: a review. Psychiatric Services 56, 332–343. doi: 10.1176/appi.ps.56.3.332
Benito-León, J., Louis, E. D., Villarejo-Galende, A., Romero, J. P., and Bermejo-Pareja, F. (2014). Long sleep duration in elders without dementia increases risk of dementia mortality (NEDICES). Neurology 83, 1530–1537. doi: 10.1212/WNL.0000000000000915
Budhiraja, R., Roth, T., Hudgel, D. W., Budhiraja, P., and Drake, C. L. (2011). Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep 34, 859–867. doi: 10.5665/sleep.1114
Cai, H., Shu, X. O., Xiang, Y. B., Yang, G., Li, H., Ji, B. T., et al. (2015). Sleep duration and mortality: a prospective study of 113 138 middle-aged and elderly Chinese men and women. Sleep 38, 529–536. doi: 10.5665/sleep.4564
Cohen-Mansfield, J., and Perach, R. (2012). Sleep duration, nap habits, and mortality in older persons. Sleep 35, 1003–1009. doi: 10.5665/sleep.1970
Daley, M., Morin, C. M., Leblanc, M., Grégoire, J. P., Savard, J., and Baillargeon, L. (2009). Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med. 10, 427–438. doi: 10.1016/j.sleep.2008.04.005
Duggan, K. A., Reynolds, C. A., Kern, M. L., and Friedman, H. S. (2014). Childhood sleep duration and lifelong mortality risk. Health Psychol. 33, 1195–1203. doi: 10.1037/hea0000078
Durrence, H. H., and Lichstein, K. L. (2006). The sleep of African Americans: a comparative review. Behav. Sleep Med. 4, 29–44. doi: 10.1207/s15402010bsm0401_3
Ensrud, K. E., Blackwell, T. L., Ancoli-Israel, S., Redline, S., Cawthon, P. M., Paudel, M. L., et al. (2012). Sleep disturbances and risk of frailty and mortality in older men. Sleep Med. 13, 1217–1225. doi: 10.1016/j.sleep.2012.04.010
Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B., and Blazer, D. G. (1995). Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18, 425–432.
Foley, D. J., Monjan, A. A., Izmirlian, G., Hays, J. C., and Blazer, D. G. (1999). Incidence and remission of insomnia among elderly adults in a biracial cohort. Sleep 22(Suppl. 2), S373–378.
Ford, E. S., Cunningham, T. J., Giles, W. H., and Croft, J. B. (2015). Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. Sleep Med. 16, 372–378. doi: 10.1016/j.sleep.2014.12.008
Gamaldo, A. A., Allaire, J. C., and Whitfield, K. E. (2010). Exploring the within-person coupling of sleep and cognition in older African Americans. Psychol. Aging 25, 851–857. doi: 10.1037/a0021378
Gamaldo, A. A., Allaire, J. C., and Whitfield, K. E. (2012a). Intraindividual variability in psychometrically defined mild cognitive impairment status in older African Americans. Psychol. Aging 27, 989–997. doi: 10.1037/a0028557
Gamaldo, C. E., Shaikh, A. K., and McArthur, J. C. (2012b). The sleep-immunity relationship. Neurol. Clin. 30, 1313–1343. doi: 10.1016/j.ncl.2012.08.007
Garde, A. H., Hansen, Å. M., Holtermann, A., Gyntelberg, F., and Suadicani, P. (2013). Sleep duration and ischemic heart disease and all-cause mortality: prospective cohort study on effects of tranquilizers/hypnotics and perceived stress. Scand. J. Work Environ. Health 39, 550–558. doi: 10.5271/sjweh.3372
Ge, X., Han, F., Huang, Y., Zhang, Y., Yang, T., Bai, C., et al. (2013). Is obstructive sleep apnea associated with cardiovascular and all-cause mortality? PLoS ONE 8:e69432. doi: 10.1371/journal.pone.0069432
Gottlieb, D. J., Punjabi, N. M., Newman, A. B., Resnick, H. E., Redline, S., Baldwin, C. M., et al. (2005). Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch. Intern. Med. 165, 863–867. doi: 10.1001/archinte.165.8.863
Groth, M. (2005). Sleep apnea in the elderly. Clin. Geriatr. Med. 21, 701–712. doi: 10.1016/j.cger.2005.06.009
Hall, M. H., Smagula, S. F., Boudreau, R. M., Ayonayon, H. N., Goldman, S. E., Harris, T. B., et al. (2015). Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the health, aging and body composition study. Sleep 38, 189–195. doi: 10.5665/sleep.4394
Howrey, B. T., Peek, M. K., Raji, M. A., Ray, L. A., and Ottenbacher, K. J. (2012). Self-reported sleep characteristics and mortality in older adults of Mexican origin: results from the Hispanic established population for the epidemiologic study of the elderly. J. Am. Geriatr. Soc. 60, 1906–1911. doi: 10.1111/j.1532-5415.2012.04144.x
Hublin, C., Partinen, M., Koskenvuo, M., and Kaprio, J. (2011). Heritability and mortality risk of insomnia-related symptoms: a genetic epidemiologic study in a population-based twin cohort. Sleep 34, 957–964. doi: 10.5665/sleep.1136
Jaramillo, C. A., Cooper, D. B., Wang, C. P., Tate, D. F., Eapen, B. C., York, G. E., et al. (2015). Subgroups of US IRAQ and Afghanistan veterans: associations with traumatic brain injury and mental health conditions. Brain Imaging Behav. 9, 445–455. doi: 10.1007/s11682-015-9402-8
Johansson, P., Alehagen, U., Svanborg, E., Dahlström, U., and Broström, A. (2012). Clinical characteristics and mortality risk in relation to obstructive and central sleep apnoea in community-dwelling elderly individuals: a 7-year follow-up. Age Ageing 41, 468–474. doi: 10.1093/ageing/afs019
Jung, K. I., Song, C. H., Ancoli-Israel, S., and Barrett-Connor, E. (2013). Gender differences in nighttime sleep and daytime napping as predictors of mortality in older adults: the Rancho Bernardo study. Sleep Med. 14, 12–19. doi: 10.1016/j.sleep.2012.06.004
Kakizaki, M., Kuriyama, S., Nakaya, N., Sone, T., Nagai, M., Sugawara, Y., et al. (2013). Long sleep duration and cause-specific mortality according to physical function and self-rated health: the Ohsaki Cohort Study. J. Sleep Res. 22, 209–216. doi: 10.1111/j.1365-2869.2012.01053.x
Kapur, V., Strohl, K. P., Redline, S., Iber, C., O'connor, G., and Nieto, J. (2002). Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath 6, 49–54. doi: 10.1055/s-2002-32318
Kaufmann, C. N., Canham, S. L., Mojtabai, R., Gum, A. M., Dautovich, N. D., Kohn, R., et al. (2013). Insomnia and health services utilization in middle-aged and older adults: results from the health and retirement study. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1512–1517. doi: 10.1093/gerona/glt050
Kaufmann, C. N., Spira, A. P., Rae, D. S., West, J. C., and Mojtabai, R. (2011). Sleep problems, psychiatric hospitalization, and emergency department use among psychiatric patients with Medicaid. Psychiatr. Serv. 62, 1101–1105. doi: 10.1176/ps.62.9.pss6209_1101
Kendzerska, T., Gershon, A. S., Hawker, G., Leung, R. S., and Tomlinson, G. (2014). Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med. 11:e1001599. doi: 10.1371/journal.pmed.1001599
Kronholm, E., Partonen, T., Laatikainen, T., Peltonen, M., Härmä, M., Hublin, C., et al. (2008). Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J. Sleep Res. 17, 54–62. doi: 10.1111/j.1365-2869.2008.00627.x
Kurina, L. M., McClintock, M. K., Chen, J. H., Waite, L. J., Thisted, R. A., and Lauderdale, D. S. (2013). Sleep duration and all-cause mortality: a critical review of measurement and associations. Ann. Epidemiol. 23, 361–370. doi: 10.1016/j.annepidem.2013.03.015
Lee, J. E., Lee, C. H., Lee, S. J., Ryu, Y., Lee, W. H., Yoon, I. Y., et al. (2013). Mortality of patients with obstructive sleep apnea in Korea. J. Clin. Sleep Med. 9, 997–1002. doi: 10.5664/jcsm.3068
Leger, D., Bayon, V., Laaban, J. P., and Philip, P. (2012). Impact of sleep apnea on economics. Sleep Med. Rev. 16, 455–462. doi: 10.1016/j.smrv.2011.10.001
Lockhart, E. M., Willingham, M. D., Abdallah, A. B., Helsten, D. L., Bedair, B. A., Thomas, J., et al. (2013). Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort. Sleep Med. 14, 407–415. doi: 10.1016/j.sleep.2012.10.018
Louis, J. M., Mogos, M. F., Salemi, J. L., Redline, S., and Salihu, H. M. (2014). Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep 37, 843–849. doi: 10.5665/sleep.3644
Lyons, P. G., Zadravecz, F. J., Edelson, D. P., Mokhlesi, B., and Churpek, M. M. (2015). Obstructive sleep apnea and adverse outcomes in surgical and nonsurgical patients on the wards. J. Hosp. Med. 10, 592–598. doi: 10.1002/jhm.2404
Marshall, N. S., Wong, K. K., Cullen, S. R., Knuiman, M. W., and Grunstein, R. R. (2014). Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J. Clin. Sleep Med. 10, 355–362. doi: 10.5664/jcsm.3600
Muraja-Murro, A., Kulkas, A., Hiltunen, M., Kupari, S., Hukkanen, T., Tiihonen, P., et al. (2013). The severity of individual obstruction events is related to increased mortality rate in severe obstructive sleep apnea. J. Sleep Res. 22, 663–669. doi: 10.1111/jsr.12070
Neikrug, A. B., and Ancoli-Israel, S. (2010). Sleep disorders in the older adult - a mini-review. Gerontology 56, 181–189. doi: 10.1159/000236900
Nieto, F. J., Peppard, P. E., Young, T., Finn, L., Hla, K. M., and Farré, R. (2012). Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am. J. Respir. Crit. Care Med. 186, 190–194. doi: 10.1164/rccm.201201-0130OC
Ohayon, M. M., Carskadon, M. A., Guilleminault, C., and Vitiello, M. V. (2004). Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 27, 1255–1273.
Olafiranye, O., Akinboboye, O., Mitchell, J. E., Ogedegbe, G., and Jean-Louis, G. (2013). Obstructive sleep apnea and cardiovascular disease in blacks: a call to action from the Association of Black Cardiologists. Am. Heart J. 165, 468–476. doi: 10.1016/j.ahj.2012.12.018
Omachi, T. A., Blanc, P. D., Claman, D. M., Chen, H., Yelin, E. H., Julian, L., et al. (2012). Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 13, 476–483. doi: 10.1016/j.sleep.2011.12.007
Ozminkowski, R. J., Wang, S., and Walsh, J. K. (2007). The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 30, 263–273.
Pallesen, S., Sivertsen, B., Nordhus, I. H., and Bjorvatn, B. (2014). A 10-year trend of insomnia prevalence in the adult Norwegian population. Sleep Med. 15, 173–179. doi: 10.1016/j.sleep.2013.10.009
Pan, A., De Silva, D. A., Yuan, J. M., and Koh, W. P. (2014). Sleep duration and risk of stroke mortality among Chinese adults: Singapore Chinese health study. Stroke 45, 1620–1625. doi: 10.1161/STROKEAHA.114.005181
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., and Hla, K. M. (2013). Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol. 177, 1006–1014. doi: 10.1093/aje/kws342
Rahman, S. A., and Adjeroh, D. (2015). Surface-based body shape index and its relationship with all-cause mortality. PLoS ONE 10:e0144639. doi: 10.1371/journal.pone.0144639
Redline, S., Tishler, P. V., Hans, M. G., Tosteson, T. D., Strohl, K. P., and Spry, K. (1997). Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am. J. Respir. Crit. Care Med. 155, 186–192. doi: 10.1164/ajrccm.155.1.9001310
Rod, N. H., Kumari, M., Lange, T., Kivimäki, M., Shipley, M., and Ferrie, J. (2014). The joint effect of sleep duration and disturbed sleep on cause-specific mortality: results from the Whitehall II cohort study. PLoS ONE 9:e91965. doi: 10.1371/journal.pone.0091965
Roepke, S. K., and Ancoli-Israel, S. (2010). Sleep disorders in the elderly. Indian J. Med. Res. 131, 302–310.
Salas, R. E., Chakravarthy, R., Sher, A., and Gamaldo, C. E. (2014). Management of sleep apnea in the neurology patient: five new things. Neurol. Clin. Practice 4, 44–52. doi: 10.1212/01.CPJ.0000442583.87327.5d
Seicean, S., Neuhauser, D., Strohl, K., and Redline, S. (2011). An exploration of differences in sleep characteristics between Mexico-born US immigrants and other Americans to address the Hispanic Paradox. Sleep 34, 1021–1031. doi: 10.5665/sleep.1154
Shear, T. C., Balachandran, J. S., Mokhlesi, B., Spampinato, L. M., Knutson, K. L., Meltzer, D. O., et al. (2014). Risk of sleep apnea in hospitalized older patients. J. Clin. Sleep Med. 10, 1061–1066. doi: 10.5664/jcsm.4098
Stanchina, M. L., Welicky, L. M., Donat, W., Lee, D., Corrao, W., and Malhotra, A. (2013). Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J. Clin. Sleep Med. 9, 767–772. doi: 10.5664/jcsm.2916
Terán-Santos, J., Jiménez-Gómez, A., and Cordero-Guevara, J. (1999). The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N.Engl J. Med. 340, 847–851. doi: 10.1056/NEJM199903183401104
Weech-Maldonado, R., Pradhan, R., and Paige Powell, M. (2014). “Medicare and Health Care Utilization,” in Handbook of Minority Aging, eds K. E. Whitfield and T. A. Baker (New York, NY: Springer Publishing Company, LLC), 539–556.
Wolkove, N., Elkholy, O., Baltzan, M., and Palayew, M. (2007). Sleep and aging: 1. Sleep disorders commonly found in older people. CMAJ 176, 1299–1304. doi: 10.1503/cmaj.060792
Xiao, Q., Keadle, S. K., Hollenbeck, A. R., and Matthews, C. E. (2014). Sleep duration and total and cause-specific mortality in a large US cohort: interrelationships with physical activity, sedentary behavior, and body mass index. Am. J. Epidemiol. 180, 997–1006. doi: 10.1093/aje/kwu222
Yeo, Y., Ma, S. H., Park, S. K., Chang, S. H., Shin, H. R., Kang, D., et al. (2013). A prospective cohort study on the relationship of sleep duration with all-cause and disease-specific mortality in the Korean Multi-center Cancer Cohort study. J. Prev. Med. Public Health 46, 271–281. doi: 10.3961/jpmph.2013.46.5.271
Keywords: sleep disturbances, sleep disorders, inpatient sample, co-morbidity, length of stay, health care cost, mortality, older adults
Citation: Gamaldo AA, Beydoun MA, Beydoun HA, Liang H, Salas RE, Zonderman AB, Gamaldo CE and Eid SM (2016) Sleep Disturbances among Older Adults in the United States, 2002–2012: Nationwide Inpatient Rates, Predictors, and Outcomes. Front. Aging Neurosci. 8:266. doi: 10.3389/fnagi.2016.00266
Received: 25 August 2016; Accepted: 24 October 2016;
Published: 15 November 2016.
Edited by:
Lia Fernandes, University of Porto, PortugalCopyright © 2016 Gamaldo, Beydoun, Beydoun, Liang, Salas, Zonderman, Gamaldo and Eid. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: May A. Beydoun, baydounm@mail.nih.gov
†Co-first authors.
‡Co-senior authors.